Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by smush74on Aug 07, 2013 5:19pm

160 Views

Post# 21655264

RE:RE:RE:Unlikely for a big pullback IMHO

I think you are confusing day traders with those that are margin trading or short selling, truthseeker. Different beast all together, not to mention that there are also various types of day traders, some cash out at the end of every day others are comfortable hold the equity over night. Last point nothing said on these boards will influence a sp price, because if you are relying on these boards for your financial advice you should no be buying stocks. Sharing of information and opinions is what these forums are for.

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports